Distribution of the C-460T polymorphism of the vascular endothelial growth factor gene in age-related macular degeneration

Klinika Oczna

Volumn 111, Issue 4-6, 2009, Pages 125-127

  Szaflik, Jacek P ^a   Btasiak, Janusz ^b   Krzyzanowska, Anna ^a   Zaraś, Matgorzata ^a   Katarzyna, Janik Papis ^b   Borucka, AnnaI ^a   Woźniak, Katarzyna ^b   Borucka, Jerzy ^a  

^a MEDICAL UNIVERSITY OF WARSAW   (Poland)

^b UNIVERSITY OF LODZ   (Poland)

Author keywords

Age related macular degeneration; AMD; Genetic polymorphism; Vascular endothelial growth factor; VEGF

Indexed keywords

VASCULOTROPIN A;

AGED; ARTICLE; COMPARATIVE STUDY; FEMALE; GENETIC PREDISPOSITION; GENETICS; GENOTYPE; HUMAN; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; RETINA MACULA DEGENERATION; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM;

AGED; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; MACULAR DEGENERATION; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 70349232896     PISSN: 00232157     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (11)

1. Montezuma SR, Sobrin L, Seddon JM.: Review of genetics in age related macular degeneration. Semin Ophthalmol 2007, 22, 229-240.
2. Lopez PF, Sippy BD, Lambert HM, Thach AB, Hinton DR: Transdifferentiated retinal pigment epithelial cells are immunoreactive for vascular endothelial growth factor in surgically excised age-related macular degeneration-related choroidal neovascular membranes. Invest Ophthalmol Vis Sci 1996, 37, 855-868.
3. Andreoli CM, Miller JW: Anti-vascular endothelial growth factor therapy for ocular neovascular disease. Curr Opin Ophthalmol 2007, 18, 502-508. (Pubitemid 351339405)
4. Houck KA, Ferrara N, Winer J, Cachianes G, Li B, Leung DW: The vascular endothelial growth factor family: Identification of a fourth molecular species and characterisation of alternative splicing of RNA. Mol Endocrinol 1991, 5, 1806-1814.
5. Ferrara N, Carver-Moore K, Chen H, Dowd M, Lu L, O'Shea KS, Powell-Braxton L, Hillan KJ, Moore MW:: Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene. Nature 1996, 380, 439-442. (Pubitemid 26102720)
6. Watson CJ, Webb NJA, Bottomley MJ, Brenchley PEC: Identification of polymorphisms within the vascular endothelial growth factor (VEGF) gene: correlation with variation in VEGF protein production. Cytokine 2000, 12, 1232-1235. (Pubitemid 30611801)
7. Lutty GA, McLeod DS, Merges C, Diggs A, Plouet J: Localization of vascular endothelial growth factor in human retina and choroid. Arch Ophthalmology 1996, 114, 971-977. (Pubitemid 26271463)
8. Bates DO, Cui TG, Doughty JM: VEGF165b, an inhibitory splice variant of vascular endothelial growth factor, is down-regulated in renal cell carcinoma. Cancer Res 2002, 62, 4123-4131. (Pubitemid 34791084)
9. Suganthalakshmi B, Anand R, Kim R, Mahalakshmi R, Karthikprakash S, Namperumalsamy P, Sundaresan P:: Association of VEGF and eNOS gene polymorphisms in type 2 diabetic retinopathy. Mol Vis 2006, 12, 336-341.
10. Perrin RM, Konopatskaya O, Qiu Y, Harper S, Bates DO, Churchill AJ: Diabetic retinopathy is associated with a switch in splicing from anti-to pro-angiogenic isoforms of vascular endothelial growth factor. Diabetologia 2005, 48, 2422-2427. (Pubitemid 41618935)
11. Szaflik JP, Wysocki T, Kowalski M, Majsterek I, Borucka Al, Blasiak J, Szaflik J: An association between vascular endothelial growth factor gene promoter polymorphisms and diabetic retinopathy. Graefes Arch Clin Exp Ophthalmol. 2008, 246, 39-43. (Pubitemid 350162682)